What are the possible side effects of NAMENDA XR?
The most common side effects associated with NAMENDA XR® (memantine hydrochloride)
treatment are headache, diarrhea, and dizziness. This is not a complete list of side effects.
Most common side effects of NAMENDA XR
The most common side effects occurring in a clinical trial in at least 2% of patients treated with
NAMENDA XR and at a rate greater than in patients given a placebo (sugar pill) are listed on the chart.
Headache, diarrhea, and dizziness occurred at a rate of at least 5% in NAMENDA XR-treated patients and
at a greater rate than in the placebo group.
NAMENDA XR 28mg+AChEI (n=341)
Infections and infestations
Musculoskeletal and connective tissue disorders
Renal and urinary disorders
Discontinuation due to side effects was 10% for the NAMENDA XR 28 mg+AChEI treatment
group and 6.3% for the placebo+AChEI treatment group. The most common side effect
that led to treatment discontinuation in this study was dizziness, at a rate of 1.5% in the
NAMENDA XR-treated group.
Looking for information about
twice-daily NAMENDA? Find it here
*ARICEPT is a registered trademark of Eisai Co., Ltd.
†RAZADYNE is a registered trademark of Johnson & Johnson.
‡EXELON is a registered trademark of Novartis AG Corp.